▶ 調査レポート

世界の頭蓋内出血治療薬市場：市場規模・現状・予測
• 英文タイトル：Global Intracranial Hemorrhage Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の頭蓋内出血治療薬市場：市場規模・現状・予測 / Global Intracranial Hemorrhage Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9N7396資料のイメージです。• レポートコード：QYR9N7396
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、頭蓋内出血治療薬のグローバル市場について調査・分析したレポートで、種類別（降圧薬、抗不安薬、高浸透圧療法、抗けいれん薬）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・頭蓋内出血治療薬の世界市場規模
・主要企業別市場シェア
・頭蓋内出血治療薬の世界市場規模：種類別（降圧薬、抗不安薬、高浸透圧療法、抗けいれん薬）
・頭蓋内出血治療薬の世界市場規模：用途別（病院、診療所、その他）
・頭蓋内出血治療薬のアメリカ市場規模（種類別、用途別）
・頭蓋内出血治療薬のヨーロッパ市場規模（種類別、用途別）
・頭蓋内出血治療薬の中国市場規模（種類別、用途別）
・頭蓋内出血治療薬の日本市場規模（種類別、用途別）
・頭蓋内出血治療薬の東南アジア市場規模（種類別、用途別）
・頭蓋内出血治療薬のインド市場規模（種類別、用途別）
・頭蓋内出血治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・頭蓋内出血治療薬の世界市場予測（2019年-2025年）
・頭蓋内出血治療薬の地域別市場予測（2019年-2025年）
...

Intracranial hemorrhage is a type of bleeding that occurs inside the skull. Intracranial Hemorrhage Medication is principally focused on adjunctive measures to minimize injury and to stabilize individuals in the perioperative phase.There are several kinds of intracranial hemorrhage medications, such as anti-hypertensive medications, anti-anxiety medications, hyperosmotic medications and anti-seizure medications.In 2018, the global Intracranial Hemorrhage Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Intracranial Hemorrhage Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intracranial Hemorrhage Therapeutics development in United States, Europe and China.

The key players covered in this study
Bayer
Boehringer Ingelheim
Johnson and Johnson
Novo Nordisk
Bristol-Myers Squibb
H. Lundbeck
Oxurion
Ligand Pharmaceuticals
Neurotec Pharma

Market segment by Type, the product can be split into
Anti-hypertensive Medicine
Anti-anxiety Medicine
Hyperosmotic Medicine
Anti-seizure Medicine

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Intracranial Hemorrhage Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Intracranial Hemorrhage Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Intracranial Hemorrhage Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Intracranial Hemorrhage Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-hypertensive Medicine
1.4.3 Anti-anxiety Medicine
1.4.4 Hyperosmotic Medicine
1.4.5 Anti-seizure Medicine
1.5 Market by Application
1.5.1 Global Intracranial Hemorrhage Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Intracranial Hemorrhage Therapeutics Market Size
2.2 Intracranial Hemorrhage Therapeutics Growth Trends by Regions
2.2.1 Intracranial Hemorrhage Therapeutics Market Size by Regions (2014-2025)
2.2.2 Intracranial Hemorrhage Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Intracranial Hemorrhage Therapeutics Market Size by Manufacturers
3.1.1 Global Intracranial Hemorrhage Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Intracranial Hemorrhage Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Intracranial Hemorrhage Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Intracranial Hemorrhage Therapeutics Key Players Head office and Area Served
3.3 Key Players Intracranial Hemorrhage Therapeutics Product/Solution/Service
3.4 Date of Enter into Intracranial Hemorrhage Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Intracranial Hemorrhage Therapeutics Market Size by Type (2014-2019)
4.2 Global Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Intracranial Hemorrhage Therapeutics Market Size (2014-2019)
5.2 Intracranial Hemorrhage Therapeutics Key Players in United States
5.3 United States Intracranial Hemorrhage Therapeutics Market Size by Type
5.4 United States Intracranial Hemorrhage Therapeutics Market Size by Application

6 Europe
6.1 Europe Intracranial Hemorrhage Therapeutics Market Size (2014-2019)
6.2 Intracranial Hemorrhage Therapeutics Key Players in Europe
6.3 Europe Intracranial Hemorrhage Therapeutics Market Size by Type
6.4 Europe Intracranial Hemorrhage Therapeutics Market Size by Application

7 China
7.1 China Intracranial Hemorrhage Therapeutics Market Size (2014-2019)
7.2 Intracranial Hemorrhage Therapeutics Key Players in China
7.3 China Intracranial Hemorrhage Therapeutics Market Size by Type
7.4 China Intracranial Hemorrhage Therapeutics Market Size by Application

8 Japan
8.1 Japan Intracranial Hemorrhage Therapeutics Market Size (2014-2019)
8.2 Intracranial Hemorrhage Therapeutics Key Players in Japan
8.3 Japan Intracranial Hemorrhage Therapeutics Market Size by Type
8.4 Japan Intracranial Hemorrhage Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Intracranial Hemorrhage Therapeutics Market Size (2014-2019)
9.2 Intracranial Hemorrhage Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Intracranial Hemorrhage Therapeutics Market Size by Type
9.4 Southeast Asia Intracranial Hemorrhage Therapeutics Market Size by Application

10 India
10.1 India Intracranial Hemorrhage Therapeutics Market Size (2014-2019)
10.2 Intracranial Hemorrhage Therapeutics Key Players in India
10.3 India Intracranial Hemorrhage Therapeutics Market Size by Type
10.4 India Intracranial Hemorrhage Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Intracranial Hemorrhage Therapeutics Market Size (2014-2019)
11.2 Intracranial Hemorrhage Therapeutics Key Players in Central & South America
11.3 Central & South America Intracranial Hemorrhage Therapeutics Market Size by Type
11.4 Central & South America Intracranial Hemorrhage Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Intracranial Hemorrhage Therapeutics Introduction
12.1.4 Bayer Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Company Details
12.2.2 Company Description and Business Overview
12.2.3 Intracranial Hemorrhage Therapeutics Introduction
12.2.4 Boehringer Ingelheim Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.2.5 Boehringer Ingelheim Recent Development
12.3 Johnson and Johnson
12.3.1 Johnson and Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Intracranial Hemorrhage Therapeutics Introduction
12.3.4 Johnson and Johnson Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.3.5 Johnson and Johnson Recent Development
12.4 Novo Nordisk
12.4.1 Novo Nordisk Company Details
12.4.2 Company Description and Business Overview
12.4.3 Intracranial Hemorrhage Therapeutics Introduction
12.4.4 Novo Nordisk Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.4.5 Novo Nordisk Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Intracranial Hemorrhage Therapeutics Introduction
12.5.4 Bristol-Myers Squibb Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 H. Lundbeck
12.6.1 H. Lundbeck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Intracranial Hemorrhage Therapeutics Introduction
12.6.4 H. Lundbeck Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.6.5 H. Lundbeck Recent Development
12.7 Oxurion
12.7.1 Oxurion Company Details
12.7.2 Company Description and Business Overview
12.7.3 Intracranial Hemorrhage Therapeutics Introduction
12.7.4 Oxurion Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.7.5 Oxurion Recent Development
12.8 Ligand Pharmaceuticals
12.8.1 Ligand Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Intracranial Hemorrhage Therapeutics Introduction
12.8.4 Ligand Pharmaceuticals Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.8.5 Ligand Pharmaceuticals Recent Development
12.9 Neurotec Pharma
12.9.1 Neurotec Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Intracranial Hemorrhage Therapeutics Introduction
12.9.4 Neurotec Pharma Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)
12.9.5 Neurotec Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Intracranial Hemorrhage Therapeutics Key Market Segments
Table Key Players Intracranial Hemorrhage Therapeutics Covered
Table Global Intracranial Hemorrhage Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Intracranial Hemorrhage Therapeutics Market Size Market Share by Type 2014-2025
Figure Anti-hypertensive Medicine Figures
Table Key Players of Anti-hypertensive Medicine
Figure Anti-anxiety Medicine Figures
Table Key Players of Anti-anxiety Medicine
Figure Hyperosmotic Medicine Figures
Table Key Players of Hyperosmotic Medicine
Figure Anti-seizure Medicine Figures
Table Key Players of Anti-seizure Medicine
Table Global Intracranial Hemorrhage Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Intracranial Hemorrhage Therapeutics Report Years Considered
Table Global Intracranial Hemorrhage Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Intracranial Hemorrhage Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Intracranial Hemorrhage Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Intracranial Hemorrhage Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Intracranial Hemorrhage Therapeutics Market Share by Regions 2014-2019
Figure Global Intracranial Hemorrhage Therapeutics Market Share by Regions 2014-2019
Figure Global Intracranial Hemorrhage Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Intracranial Hemorrhage Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Intracranial Hemorrhage Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Intracranial Hemorrhage Therapeutics Market Share by Manufacturers in 2018
Table Global Intracranial Hemorrhage Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Intracranial Hemorrhage Therapeutics Product/Solution/Service
Table Date of Enter into Intracranial Hemorrhage Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Intracranial Hemorrhage Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Intracranial Hemorrhage Therapeutics Market Size Share by Type (2014-2019)
Figure Global Intracranial Hemorrhage Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Intracranial Hemorrhage Therapeutics Market Size Share by Application (2014-2019)
Figure Global Intracranial Hemorrhage Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Intracranial Hemorrhage Therapeutics Revenue Market Share by Application in 2018
Figure United States Intracranial Hemorrhage Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Intracranial Hemorrhage Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Intracranial Hemorrhage Therapeutics Market Share (2018-2019)
Table United States Intracranial Hemorrhage Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Intracranial Hemorrhage Therapeutics Market Share by Type (2014-2019)
Table United States Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Intracranial Hemorrhage Therapeutics Market Share by Application (2014-2019)
Figure Europe Intracranial Hemorrhage Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Intracranial Hemorrhage Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Intracranial Hemorrhage Therapeutics Market Share (2018-2019)
Table Europe Intracranial Hemorrhage Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Intracranial Hemorrhage Therapeutics Market Share by Type (2014-2019)
Table Europe Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Intracranial Hemorrhage Therapeutics Market Share by Application (2014-2019)
Figure China Intracranial Hemorrhage Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Intracranial Hemorrhage Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Intracranial Hemorrhage Therapeutics Market Share (2018-2019)
Table China Intracranial Hemorrhage Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Intracranial Hemorrhage Therapeutics Market Share by Type (2014-2019)
Table China Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Intracranial Hemorrhage Therapeutics Market Share by Application (2014-2019)
Figure Japan Intracranial Hemorrhage Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Intracranial Hemorrhage Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Intracranial Hemorrhage Therapeutics Market Share (2018-2019)
Table Japan Intracranial Hemorrhage Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Intracranial Hemorrhage Therapeutics Market Share by Type (2014-2019)
Table Japan Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Intracranial Hemorrhage Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Intracranial Hemorrhage Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Intracranial Hemorrhage Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Intracranial Hemorrhage Therapeutics Market Share (2018-2019)
Table Southeast Asia Intracranial Hemorrhage Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Intracranial Hemorrhage Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Intracranial Hemorrhage Therapeutics Market Share by Application (2014-2019)
Figure India Intracranial Hemorrhage Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Intracranial Hemorrhage Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Intracranial Hemorrhage Therapeutics Market Share (2018-2019)
Table India Intracranial Hemorrhage Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Intracranial Hemorrhage Therapeutics Market Share by Type (2014-2019)
Table India Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Intracranial Hemorrhage Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Intracranial Hemorrhage Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Intracranial Hemorrhage Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Intracranial Hemorrhage Therapeutics Market Share (2018-2019)
Table Central & South America Intracranial Hemorrhage Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Intracranial Hemorrhage Therapeutics Market Share by Type (2014-2019)
Table Central & South America Intracranial Hemorrhage Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Intracranial Hemorrhage Therapeutics Market Share by Application (2014-2019)
Table Bayer Company Details
Table Bayer Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019) (Million US$)
Figure Bayer Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)(Million US$)
Figure Johnson and Johnson Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table Johnson and Johnson Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table Novo Nordisk Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)(Million US$)
Figure H. Lundbeck Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table H. Lundbeck Recent Development
Table Oxurion Company Details
Table Oxurion Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)(Million US$)
Figure Oxurion Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table Oxurion Recent Development
Table Ligand Pharmaceuticals Company Details
Table Ligand Pharmaceuticals Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)(Million US$)
Figure Ligand Pharmaceuticals Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table Ligand Pharmaceuticals Recent Development
Table Neurotec Pharma Company Details
Table Neurotec Pharma Revenue in Intracranial Hemorrhage Therapeutics Business (2014-2019)(Million US$)
Figure Neurotec Pharma Revenue Growth Rate in Intracranial Hemorrhage Therapeutics Business (2014-2019)
Table Neurotec Pharma Recent Development
Table Global Intracranial Hemorrhage Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Intracranial Hemorrhage Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Intracranial Hemorrhage Therapeutics Market Size Share by Regions in 2025
Figure United States Intracranial Hemorrhage Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Intracranial Hemorrhage Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Intracranial Hemorrhage Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Intracranial Hemorrhage Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Intracranial Hemorrhage Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Intracranial Hemorrhage Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Intracranial Hemorrhage Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Intracranial Hemorrhage Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Intracranial Hemorrhage Therapeutics Market Size by Product (2019-2025)
Figure Global Intracranial Hemorrhage Therapeutics Market Size by Product in 2025
Table Global Intracranial Hemorrhage Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Intracranial Hemorrhage Therapeutics Market Size by Application (2019-2025)
Figure Global Intracranial Hemorrhage Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の産後出血（PPH）治療デバイス市場2019
    Global Postpartum Hemorrhage (PPH) Treatment Devices Sales Market Report 2019
    QYR9N3652 2019年6月13日 115Pages
    本調査レポートでは、産後出血（PPH）治療デバイスの世界市場について調査・分析し、産後出血（PPH）治療デバイスのメーカー別販売量、市場シェア分析、種類別販売分析（非空気式耐衝撃ガーメント（NASG）、プレフィルドインジェクションシステム、子宮バルーンタンポナーデ、その他）、用途別販売分析（病院、診...
  • 世界の頭蓋内圧モニター市場2019
    Global Intracranial Pressure Monitor Sales Market Report 2019
    QYR9N2017 2019年6月10日 100Pages
    本調査レポートでは、頭蓋内圧モニターの世界市場について調査・分析し、頭蓋内圧モニターのメーカー別販売量、市場シェア分析、種類別販売分析（侵襲的、非侵襲的）、用途別販売分析（病院、家、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含...
  • 世界の非侵襲的頭蓋内圧モニター市場2019
    Global Non-invasive Intracranial Pressure Monitor Sales Market Report 2019
    QYR9N2930 2019年6月13日 116Pages
    本調査レポートでは、非侵襲的頭蓋内圧モニターの世界市場について調査・分析し、非侵襲的頭蓋内圧モニターのメーカー別販売量、市場シェア分析、種類別販売分析（音声信号の検出、血流シグナル検出）、用途別販売分析（脳血流モニタリング、神経電気生理学的モニタリング、脳代謝モニタリング）、地域別販売分析（米国、ヨ...
  • 世界の過活動膀胱治療学市場：市場規模・現状・予測
    Global Overactive Bladder Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7750 2019年6月14日 92Pages
    当資料は、過活動膀胱治療学のグローバル市場について調査・分析したレポートで、種類別（抗コリン作用薬、ミラベグロン、ボトックス）、用途別（特発性過活動膀胱、神経性過活動膀胱）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界の骨粗鬆症治療薬市場：市場規模・現状・予測
    Global Osteoporosis Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7734 2019年6月14日 94Pages
    当資料は、骨粗鬆症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗吸収薬、同化薬）、用途別（男性、女性）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・骨粗鬆症治療薬の...
  • 世界の閉経後骨粗鬆症治療薬市場：市場規模・現状・予測
    Global Postmenopausal Osteoporosis Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7867 2019年6月14日 97Pages
    当資料は、閉経後骨粗鬆症治療薬のグローバル市場について調査・分析したレポートで、種類別（ビスホスホネート、ホルモン、ストロンチウムラネレート、ラロキシフェン、デノスマブ、その他）、用途別（病院薬局、オンライン薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）...
  • 世界の脂質異常症治療薬市場：市場規模・現状・予測
    Global Dyslipidemia Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7136 2019年6月14日 93Pages
    当資料は、脂質異常症治療薬のグローバル市場について調査・分析したレポートで、種類別（スタチン、非スタチン、組み合わせ薬）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。<...
  • 世界のデジタル治療薬＆ウェルネス市場：市場規模・現状・予測
    Global Digital Therapeutics & Wellness Market Size, Status and Forecast 2019-2025
    QYR9N7107 2019年6月14日 107Pages
    当資料は、デジタル治療薬＆ウェルネスのグローバル市場について調査・分析したレポートで、種類別（ソフトウェア、デバイス）、用途別（心血管疾患と高血圧、糖尿病と前糖尿病、肥満と減量、禁煙、その他のデジタル治療学）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...
  • 世界の獣医感染症治療薬市場：市場規模・現状・予測
    Global Veterinary Infectious Disease Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N8175 2019年6月14日 98Pages
    当資料は、獣医感染症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗生物質、抗ウイルス薬、抗真菌、殺虫剤、駆虫薬）、用途別（獣医病院、獣医クリニック、獣医薬局、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の酒さ治療薬市場：市場規模・現状・予測
    Global Rosacea Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7983 2019年6月14日 93Pages
    当資料は、酒さ治療薬のグローバル市場について調査・分析したレポートで、種類別（抗菌剤、アルファアゴニスト、レチノイド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界の個別化医療市場：市場規模・現状・予測世界の個別化医療市場：市場規模・現状・予測 Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effect…
  • 世界のホメオパシー医学市場：市場規模・現状・予測世界のホメオパシー医学市場：市場規模・現状・予測 Homeopathy is a field of alternative medicine, introduced by Samuel Hahnemann in 1976. It works on the principle of similarity of symptoms i.e. a substance causing symptoms of disease in healthy individual will show same symptoms in the sick. Homeopathic medicine include treatment using natural sour…
  • 世界の東洋医学市場：市場規模・現状・予測世界の東洋医学市場：市場規模・現状・予測 Traditional Chinese Medicine (TCM), a discipline dealing with the study of physiology, pathology, diagnosis and prevention and treatment of diseases.In 2018, the global Traditional Chinese Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a C…
  • 世界の個別化医療とエピゲノム市場：市場規模・現状・予測世界の個別化医療とエピゲノム市場：市場規模・現状・予測 Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.In 2018, the global Personalized Medicine and Epigenomics ma…
  • 世界の産後出血（PPH）治療デバイス市場2019世界の産後出血（PPH）治療デバイス市場2019 The global Postpartum Hemorrhage (PPH) Treatment Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Postpartum Hemorrhage (PPH) Treatment Devices market status and forecast, categorizes…